The Value of Five Novel Anthropometric Indicators in Evaluating MASLD and Liver Fibrosis in MASLD : A Cross‐Sectional Study
JGH Open · 2026-07 · 10 (7)
DOI: 10.1002/jgh3.70435 ↗Kurz gefasst
Fachartikel in der Zeitschrift JGH Open, online erschienen am 08.07.2026. Verfasst von Huiya Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine Wuming Hospital of Guangxi Medical University Nanning Guangxi China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic dysfunction‐associated fatty liver disease (MASLD) is the most prevalent chronic liver disease globally. Early screening is critical for preventing liver fibrosis (LF) and cirrhosis, but liver biopsy and imaging are costly and less accessible in primary care settings. Simple, economical anthropometric indicators are urgently needed for large‐scale initial screening.
Methods
Using data from NHANES 2017–2020, we applied logistic regression, generalized additive models, and ROC analysis to evaluate five novel anthropometric indices (BRI, LAP, WTI, WWI, and ABSI) for predicting MASLD and LF in individuals with MASLD.
Results
All indices showed significant positive dose–response associations with MASLD risk (fully adjusted ORs: BRI, 1.86; LAP, 1.03; WTI, 5.31; WWI, 3.31; and ABSI, 2.13). BRI and LAP demonstrated the highest predictive performance for MASLD (AUC = 0.82). For LF among individuals with MASLD, BRI (AUC = 0.71) outperformed FIB‐4 and APRI. Stratified analyses revealed sex‐, age‐, and BMI‐related differences: WTI performed better in women; ABSI and BRI in men; WWI, ABSI, and BRI in younger adults; and BRI in lean individuals. Nonlinear associations with MASLD were observed for all indices, whereas only WWI showed a linear association with LF.
Conclusions
BRI is independently associated with MASLD and LF in individuals with MASLD and demonstrates superior predictive performance and clinical net benefit compared with other noninvasive models. These findings support its potential use for the early identification of MASLD and LF risk in primary care settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Medicine Wuming Hospital of Guangxi Medical University Nanning Guangxi China.
- Department of Infectious Diseases Wuming Hospital of Guangxi Medical University Nanning Guangxi China.
- Department of Gastroenterology The People's Hospital of Laibin City Laibin Guangxi China.
- Dean's Office Youjiang Medical University for Nationalities Baise Guangxi China.
- School of General Practice Guangxi Medical University Nanning Guangxi China.
ORCID-Profile: Huiya Huang
Zitieren
APA
Huang, H., Lu, Y., Luo, T., Wu, H., Li, J., Tang, T., Xv, X., Wu, J., & Chen, M. (2026). The Value of Five Novel Anthropometric Indicators in Evaluating MASLD and Liver Fibrosis in MASLD : A Cross‐Sectional Study. JGH Open, 10(7). https://doi.org/10.1002/jgh3.70435
Vancouver
Huang H, Lu Y, Luo T, Wu H, Li J, Tang T, et al. The Value of Five Novel Anthropometric Indicators in Evaluating MASLD and Liver Fibrosis in MASLD : A Cross‐Sectional Study. JGH Open. 2026;10(7). doi:10.1002/jgh3.70435
BibTeX
@article{Huang2026,
author = {Huang, Huiya and Lu, Yangni and Luo, Tong and Wu, Huabei and Li, Jinfeng and Tang, Tingting and Xv, Xianli and Wu, Jianlin and Chen, Maowei},
title = {The Value of Five Novel Anthropometric Indicators in Evaluating MASLD and Liver Fibrosis in MASLD : A Cross‐Sectional Study},
journal = {JGH Open},
year = {2026},
volume = {10},
number = {7},
doi = {10.1002/jgh3.70435}
}
EUVIMED